Despite research showing that adverse reactions to the epilepsy drug Carbamazepine are highly frequent, patients who have such reactions will not qualify for the Department of Health’s (DOH) drug relief program because the drug is mainly prescribed by doctors for “off-label” use, Democratic Progressive Party (DPP) Legislator Huang Sue-ying (黃淑英) said yesterday.
At a press conference yesterday, Huang cited the case of a man, surnamed Hsu (徐), who had experienced an adverse reaction to the drug but could not receive drug relief compensation, saying that this highlighted a serious problem caused by the failure of the health authorities to provide the public with protection against drugs that were prescribed off-label.
Doctors may legally prescribe drugs off-label if the drug is safe to use and found to be effective in treating a certain condition that it has not yet been approved for. For example, Carbamazepine, which has been officially approved for use in treating epilepsy, is also often prescribed by doctors as a mood stabilizer or pain reliever.
“While it is legal for doctors to prescribe drugs off-label, patients who follow their doctor’s instructions to take the drug cannot receive any help or compensation if they have an adverse reaction because the DOH’s drug relief program then deems off-label use illegal, which is unreasonable,” Huang said.
Huang cited statistics from the Drug Relief Foundation, which showed that from 2005 until last year, there were 299 cases of patients who had adverse reactions to drugs but could not receive compensation. Of the 299 cases, 101 (34 percent) were patients who used off-label drugs.
She also cited a research study by Academia Sinica in April 2004 that showed as many as 5 percent of people in Taiwan carry a gene that has shown to increase the risk of developing Stevens Johnson syndrome as a reaction to taking Carbamazepine. As a result, compared with the relatively low rate of white Caucasians who carry this gene, Taiwanese are 30 times more at risk of developing the syndrome in reaction to the drug.
Huang urged DOH officials to re-evaluate whether Carbamazepine should be legally approved as safe for use in the country, as well as provide drug relief for patients who suffer from adverse drug reactions as a result of off-label use.
Hsu Chien-wen (喋??, deputy director of the Food and Drug Administration’s division of drug and new biotechnology products, said that as no drug is 100 percent safe, doctors are advised to continue monitoring patients’ progress while they are taking them.
She said DOH officials would invite experts to discuss drug relief assistance and compensation.
SPACE VETERAN: Kjell N. Lindgren, who helps lead NASA’s human spaceflight missions, has been on two expeditions on the ISS and has spent 311 days in space Taiwan-born US astronaut Kjell N. Lindgren is to visit Taiwan to promote technological partnerships through one of the programs organized by the US for its 250th national anniversary. Lindgren would be in Taiwan from Tuesday to Saturday next week as part of the US Bureau of Educational and Cultural Affairs’ US Speaker Program, organized to celebrate the 250th anniversary of the signing of the Declaration of Independence, the American Institute in Taiwan (AIT) said in a statement yesterday. Lindgren plans to engage with key leaders across the nation “to advance cutting-edge technological partnerships and inspire the next generation of scientists and engineers,”
UNREASONABLE SURVEILLANCE: A camera targeted on an road by a neighbor captured a man’s habitual unsignaled turn into home, netting him dozens of tickets The Taichung High Administrative Court has canceled all 45 tickets given to a man for failing to use a turn signal while driving, as it considered long-term surveillance of his privacy more problematic than the traffic violations. The man, surnamed Tseng (曾), lives in Changhua County and was reported 45 times within a month for failing to signal while driving when he turned into the alley where his residence is. The reports were filed by his neighbor, who set up security cameras that constantly monitored not only the alley but also the door and yard of Tseng’s house. The surveillance occurred from July
A Japan Self-Defense Forces vessel entered the Taiwan Strait yesterday, Japanese media reported. After passing through the Taiwan Strait, the Ikazuchi was to proceed to the South China Sea to take part in a joint military exercise with the US and the Philippines, the reports said. Japan Self-Defense Force vessels were first reported to have passed through the strait in September, 2024, with two further transits taking place in February and June last year, the Asahi Shimbun reported. Yesterday’s transit also marked the first time since Japanese Prime Minister Sanae Takaichi took office that a Japanese warship has been sent through the Taiwan
‘SAME OLD TRICK’: Even if Beijing resumes individual travel to Taiwan, it would only benefit Chinese tourism companies, the Economic Democracy Union convener said China’s 10 new “incentives” are “sugar-coated poison,” an official said yesterday, adding that Taiwanese businesses see them clearly for what they are, but that Beijing would inevitably find some local collaborators to try to drums up support. The official, speaking on condition of anonymity, made the remark ahead of a news conference the General Chamber of Commerce is to hold today. The event, titled “Industry Perspectives on China’s Recent Pro-Taiwan Policies,” is expected to include representatives from industry associations — such as those in travel, hotels, food and agriculture — to request the government cooperate with China’s new measures, people familiar with
RSS